rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CERS
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Cerus Corporation Q3 2026 Earnings Call Summary
      Nov 3Yahoo FinanceCERS
      Cerus: 3 Key Takeaways for Long-Term Investors | The Motley Fool

      A shift to higher-margin kit distribution and a successful red blood cell trial position Cerus for path to GAAP profitability.

      Nov 3The Motley FoolCERS
      Cerus (CERS) Q3 2026 Earnings Call Transcript
      Nov 3The Globe and MailCERS
      Cerus Corp (CERS) Q3 2026 Earnings Call Highlights: Revenue Climbs 10% as Adjusted EBITDA ...

      Cerus Corp (CERS) reaffirmed full-year product revenue guidance of $229 million to $231 million while posting a GAAP net loss under $1 million and positive operating cash flow of $3 million.

      Nov 3Yahoo FinanceCERS
      Cerus Q3 Earnings Call Highlights
      Nov 3Yahoo FinanceCERS
      Cerus: Q3 Earnings Snapshot

      (CERS) on Monday reported a loss of $550,000 in its third quarter.The Concord, California-based company said it had a loss of less than 1 cent on a per-share basis.

      Nov 2Yahoo FinanceCERS
      Cerus Q3 2026 Earnings Call Transcript
      Nov 2BenzingaCERS
      Cerus reports positive phase 3 trial results for red blood cells
      Nov 2Investing.comCERS
      Cerus Corporation Announces Third Quarter 2026 Financial Results
      Nov 2Yahoo FinanceCERS
      Cerus Corporation to Release Third Quarter 2026 Financial Results on November 2, 2026
      Oct 19Yahoo FinanceCERS
      Cerus Corporation Announces Workshop and Abstracts at the 2026 AABB Annual Meeting

      CONCORD, Calif., October 14, 2026--Cerus Corporation (Nasdaq: CERS) announced today that it will host an industry workshop on the implementation and real-world experience with INTERCEPT Platelets and INTERCEPT Fibrinogen Complex, or IFC*, at the 2026 Association for the Advancement of Blood and Biotherapies (AABB) Annual Meeting, taking place in Atlanta, Georgia from October 17 through October 19. The AABB Annual Meeting attracts healthcare professionals, scientists, and other experts from aroun

      Oct 14Yahoo FinanceCERS

      This is the newest page. Registered accounts read further back.